Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.

Bayarri-Olmos, Rafael; Johnsen, Laust Bruun; Rosbjerg, Anne; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole

Bayarri-Olmos, Rafael; Johnsen, Laust Bruun; Rosbjerg, Anne; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole.

Bayarri-Olmos R; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Johnsen LB; Novo Nordisk A/S, Måløv, Denmark.
Rosbjerg A; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Helgstrand C; Novo Nordisk A/S, Måløv, Denmark.
Bak-Thomsen T; Novo Nordisk A/S, Måløv, Denmark.
Garred P; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Skjoedt MO; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: moskjoedt@sund.ku.dk.

J Biol Chem ; 297(5): 101241, 2021 11.

Article in English | MEDLINE | ID: covidwho-1545134

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Neutralizing; Humans; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Variants Limits: Humans Language: English Journal: J Biol Chem Year: 2021 Document Type: Article Affiliation country: J.jbc.2021.101241

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google